Sorin Group Receives Conditional FDA Approval to Conduct IDE Clinical ...

Sorin Group Receives Conditional FDA Approval to Conduct IDE Clinical Trial for Perceval S Sutureless Aortic Valve in the United States Primary objective of the prospective, non randomized trial is to demonstrate the safety and effectiveness of the PERCEVAL S sutureless valve in support of receiving FDA PMA clearance )--Sorin Group, , a global ... (more)

http://eon.businesswire.com/news/eon/20130429005429/en/Sorin-Group-Receives-Conditional-FDA-Approval-Conduct